Literature DB >> 25613324

Dissecting human skeletal muscle troponin proteoforms by top-down mass spectrometry.

Yi-Chen Chen1, Marius P Sumandea, Lars Larsson, Richard L Moss, Ying Ge.   

Abstract

Skeletal muscles are the most abundant tissues in the human body. They are composed of a heterogeneous collection of muscle fibers that perform various functions. Skeletal muscle troponin (sTn) regulates skeletal muscle contraction and relaxation. sTn consists of 3 subunits, troponin I (TnI), troponin T (TnT), and troponin C (TnC). TnI inhibits the actomyosin Mg(2+)-ATPase, TnC binds Ca(2+), and TnT is the tropomyosin (Tm)-binding subunit. The cardiac and skeletal isoforms of Tn share many similarities but the roles of modifications of Tn in the two muscles may differ. The modifications of cardiac Tn are known to alter muscle contractility and have been well-characterized. However, the modification status of sTn remains unclear. Here, we have employed top-down mass spectrometry (MS) to decipher the modifications of human sTnT and sTnI. We have extensively characterized sTnT and sTnI proteoforms, including alternatively spliced isoforms and post-translationally modified forms, found in human skeletal muscle with high mass accuracy and comprehensive sequence coverage. Moreover, we have localized the phosphorylation site of slow sTnT isoform III to Ser1 by tandem MS with electron capture dissociation. This is the first study to comprehensively characterize human sTn and also the first to identify the basal phosphorylation site for human sTnT by top-down MS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25613324      PMCID: PMC4427557          DOI: 10.1007/s10974-015-9404-6

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  62 in total

Review 1.  Human skeletal muscle fiber type classifications.

Authors:  W Scott; J Stevens; S A Binder-Macleod
Journal:  Phys Ther       Date:  2001-11

2.  Extending top-down mass spectrometry to proteins with masses greater than 200 kilodaltons.

Authors:  Xuemei Han; Mi Jin; Kathrin Breuker; Fred W McLafferty
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

Review 3.  Isoform diversity, regulation, and functional adaptation of troponin and calponin.

Authors:  Jian-Ping Jin; Zhiling Zhang; James A Bautista
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

Review 4.  Fiber types in mammalian skeletal muscles.

Authors:  Stefano Schiaffino; Carlo Reggiani
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

Review 5.  Top-down proteomics in health and disease: challenges and opportunities.

Authors:  Zachery R Gregorich; Ying Ge
Journal:  Proteomics       Date:  2014-05       Impact factor: 3.984

Review 6.  Regulation of cardiac contractile function by troponin I phosphorylation.

Authors:  Joanne Layland; R John Solaro; Ajay M Shah
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

7.  The functional properties of human slow skeletal troponin T isoforms in cardiac muscle regulation.

Authors:  Jose Renato Pinto; Aldrin V Gomes; Michelle A Jones; Jingsheng Liang; Susan Nguyen; Todd Miller; Michelle S Parvatiyar; James D Potter
Journal:  J Biol Chem       Date:  2012-09-12       Impact factor: 5.157

8.  In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated.

Authors:  Serife Ayaz-Guner; Jiang Zhang; Lin Li; Jeffery W Walker; Ying Ge
Journal:  Biochemistry       Date:  2009-09-01       Impact factor: 3.162

9.  The impact of antibody selection on the detection of cardiac troponin I.

Authors:  Moltu J Guy; Yi-Chen Chen; Laura Clinton; Han Zhang; Jiang Zhang; Xintong Dong; Qingge Xu; Serife Ayaz-Guner; Ying Ge
Journal:  Clin Chim Acta       Date:  2012-10-26       Impact factor: 3.786

10.  Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases.

Authors:  Alan J Russell; James J Hartman; Aaron C Hinken; Alexander R Muci; Raja Kawas; Lena Driscoll; Guillermo Godinez; Kenneth H Lee; David Marquez; William F Browne; Michael M Chen; David Clarke; Scott E Collibee; Marc Garard; Richard Hansen; Zhiheng Jia; Pu-Ping Lu; Hector Rodriguez; Khalil G Saikali; Julia Schaletzky; Vipin Vijayakumar; Daniel L Albertus; Dennis R Claflin; David J Morgans; Bradley P Morgan; Fady I Malik
Journal:  Nat Med       Date:  2012-02-19       Impact factor: 53.440

View more
  5 in total

1.  Ca2+ dependency of limb muscle fiber contractile mechanics in young and older adults.

Authors:  Laura E Teigen; Christopher W Sundberg; Lauren J Kelly; Sandra K Hunter; Robert H Fitts
Journal:  Am J Physiol Cell Physiol       Date:  2020-04-29       Impact factor: 4.249

2.  Effective top-down LC/MS+ method for assessing actin isoforms as a potential cardiac disease marker.

Authors:  Yi-Chen Chen; Serife Ayaz-Guner; Ying Peng; Nicole M Lane; Matthew Locher; Takushi Kohmoto; Lars Larsson; Richard L Moss; Ying Ge
Journal:  Anal Chem       Date:  2015-07-31       Impact factor: 6.986

3.  Ursolic acid supplementation decreases markers of skeletal muscle damage during resistance training in resistance-trained men: a pilot study.

Authors:  Hyun Seok Bang; Dae Yun Seo; Young Min Chung; Do Hyung Kim; Sam-Jun Lee; Sung Ryul Lee; Hyo-Bum Kwak; Tae Nyun Kim; Min Kim; Kyoung-Mo Oh; Young Jin Son; Sanghyun Kim; Jin Han
Journal:  Korean J Physiol Pharmacol       Date:  2017-10-30       Impact factor: 2.016

4.  The Human Proteoform Atlas: a FAIR community resource for experimentally derived proteoforms.

Authors:  Michael A R Hollas; Matthew T Robey; Ryan T Fellers; Richard D LeDuc; Paul M Thomas; Neil L Kelleher
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

5.  Mapping the Proteoform Landscape of Five Human Tissues.

Authors:  Bryon S Drown; Kevin Jooß; Rafael D Melani; Cameron Lloyd-Jones; Jeannie M Camarillo; Neil L Kelleher
Journal:  J Proteome Res       Date:  2022-04-12       Impact factor: 5.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.